UPFRONT HYSTERECTOMY PLUS METHOTREXATE VERSUS CHEMOTHERAPY IN MANAGEMENT OF LOW-RISK GESTATIONAL TROPHOBLASTIC NEOPLASIA IN PATIENTS AT 40 YEARS OR OLDER. A PROSPECTIVE STUDY

被引：0
|
作者：
Hemida, Reda [1 ]
Othman, Medhat [2 ]
Foda, Ashraf [3 ]
Eid, Mohammed [3 ]
机构：
[1] Mansoura Univ, Dept Obstet & Gynecol, Gynecol Oncol Unit, Mansoura, Egypt
[2] Mansoura Univ, Dept Obstet & Gynecol, GTD Clin, Mansoura, Egypt
[3] Mansoura Univ, Dept Obstet & Gynecol, Mansoura, Egypt
来源：
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER | 2023年 / 33卷
关键词：
D O I：
10.1136/ijgc-2023-ESGO.792
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
235
引用
收藏
页码：A374 / A374
页数：1
相关论文
共 50 条
  • [1] Upfront Hysterectomy Versus Primary Chemotherapy in the Management of Low-Risk Gestational Trophoblastic Neoplasia at Old Age Patients: A Prospective Study
    Othman, Medhat
    Hemida, Reda
    Foda, Ashraf
    Eid, Mohamed Ibrahem
    INDIAN JOURNAL OF GYNECOLOGIC ONCOLOGY, 2024, 22 (02)
  • [2] Immunotherapy Versus Chemotherapy for Methotrexate-Resistant Low-Risk Gestational Trophoblastic Neoplasia
    Lurain, John R.
    Schink, Julian C.
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (36) : 4349 - +
  • [3] Immunotherapy Versus Chemotherapy for Methotrexate-Resistant Low-Risk Gestational Trophoblastic Neoplasia Reply
    You, Benoit
    Bolze, Pierre-Adrien
    Golfier, Francois
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (36) : 4350 - +
  • [4] Evaluating Methotrexate Treatment in Patients With Low-Risk Postmolar Gestational Trophoblastic Neoplasia
    Growdon, Whitfield B.
    Wolfberg, Adam J.
    Goldstein, Donald P.
    Feltmate, Colleen M.
    Chinchilla, Manuel E.
    Lieberman, Ellice S.
    Berkowitz, Ross S.
    OBSTETRICAL & GYNECOLOGICAL SURVEY, 2009, 64 (05) : 308 - 309
  • [5] Evaluating methotrexate treatment in patients with low-risk postmolar gestational trophoblastic neoplasia
    Growdon, Whitfield B.
    Wolfberg, Adam J.
    Goldstein, Donald P.
    Feltmate, Colleen M.
    Chinchilla, Manuel E.
    Lieberman, Ellice S.
    Berkowitz, Ross S.
    GYNECOLOGIC ONCOLOGY, 2009, 112 (02) : 353 - 357
  • [6] Response to Chemotherapy in Overweight/Obese Patients With Low-Risk Gestational Trophoblastic Neoplasia
    Maesta, Izildinha
    Horowitz, Neil S.
    Goldstein, Donald P.
    Bernstein, Marilyn R.
    Ramirez, Luz Angela C.
    Moulder, Janelle
    Berkowitz, Ross S.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2015, 25 (04) : 734 - 740
  • [7] Methotrexate for 2000 FIGO low-risk gestational trophoblastic neoplasia patients: efficacy and toxicity
    Chalouhi, Gihad Elias
    Golfier, Francois
    Soignon, Pauline
    Massardier, Jerome
    Guastalla, Jean-Paul
    Trillet-Lenoir, Veronique
    Schott, Anne-Marie
    Raudrant, Daniel
    AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2009, 200 (06) : 643.e1 - 643.e6
  • [8] Eight days versus weekly intramuscular methotrexate for the treatment of low-risk gestational trophoblastic neoplasia
    Anfinan, N. M.
    Al Khatieb, M. T.
    Sait, H. K.
    Sait, M. K.
    Baghlaf, O. A.
    Mousa, A. A.
    Sait, K. H.
    EUROPEAN JOURNAL OF GYNAECOLOGICAL ONCOLOGY, 2020, 41 (02) : 227 - 232
  • [9] Pulse methotrexate versus pulse actinomycin D in the treatment of low-risk gestational trophoblastic neoplasia
    Yarandi, Fariba
    Eftekhar, Zahra
    Shojaei, Hadi
    Kanani, Soheyla
    Sharifi, Ali
    Hanjani, Parviz
    INTERNATIONAL JOURNAL OF GYNECOLOGY & OBSTETRICS, 2008, 103 (01) : 33 - 37
  • [10] Hysterectomy versus chemotherapy for low-risk non-metastatic gestational trophoblastic neoplasia (GTN): A cost-effectiveness analysis
    Mitric, Cristina
    Sayyid, Rashid K.
    Fleshner, Neil E.
    Hong, Nicole J. Look
    Bouchard-Fortier, Genevieve
    GYNECOLOGIC ONCOLOGY, 2024, 187 : 30 - 36
12345